HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities.
HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities.
复制标题
DOI:
10.1007/s11481-010-9205-z
复制
发表时间:
2010-09
影响因子:
6.2
通讯作者:
Jordan-Sciutto, Kelly L.
中科院分区:
文献类型:
--
作者:
Lindl, Kathryn A.;Marks, David R.;Kolson, Dennis L.;Jordan-Sciutto, Kelly L.
关键词:
Human immunodeficiency virus type 1 (HIV) infection presently affects more that 40 million people worldwide, and is associated with central nervous system (CNS) disruption in at least 30% of infected individuals. The use of highly active antiretroviral therapy has lessened the incidence, but not the prevalence of mild impairment of higher cognitive and cortical functions (HIV-associated neurocognitive disorders) as well as substantially reduced a more severe form dementia (HIV-associated dementia). Furthermore, improving neurological outcomes will require novel, adjunctive therapies that are targeted towards mechanisms of HIV-induced neurodegeneration. Identifying such molecular and pharmacological targets requires an understanding of the events preceding irreversible neuronal damage in the CNS, such as actions of neurotoxins (HIV proteins and cellular factors), disruption of ion channel properties, synaptic damage, and loss of adult neurogenesis. By considering the specific mechanisms and consequences of HIV neuropathogenesis, unified approaches for neuroprotection will likely emerge using a tailored, combined, and non-invasive approach.
登录
查看更多内容
影响因子:
3.7
作者:
Benedict, C;Hallschmid, M;Kern, W
通讯作者:
Kern, W
影响因子:
82.9
作者:
Chen, M;Ona, VO;Friedlander, RM
通讯作者:
Friedlander, RM
DOI:
10.1152/ajpendo.00167.2007
发表时间:
2008-03-01
影响因子:
5.1
作者:
Carper, Michael J.;Cade, W. Todd;Ramanadham, Sasanka
通讯作者:
Ramanadham, Sasanka
影响因子:
11.2
作者:
Arvin, KL;Han, BH;Holtzman, DM
通讯作者:
Holtzman, DM
影响因子:
3.5
作者:
Cooper-Kuhn, CM;Vroemen, M;Kuhn, HG
通讯作者:
Kuhn, HG